Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2026-01-22 @ 5:40 PM
Study NCT ID:
NCT05822102
Status:
UNKNOWN
Last Update Posted:
2023-07-24
First Post:
2023-04-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographY
Sponsor:
National Jewish Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-07
First Submit QC Date:
None
Study First Post Date:
2023-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-21
Last Update Post Date:
2023-07-24
Last Update Post Date Type:
ACTUAL